Leading Pharmaceutical Innovation

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D. Our findings are illustrated not only in cases of Swiss pharmaceutical industry, but also by industry cases from the US and Asia.

The book is based on the three most important challenges in pharmaceutical innovation: productivity dilemma, new technology trends, globalization and outsourcing Due to the CTO-roundtable with 14 selected international experts in pharmaceutical R&D whose result is presented, the book has a strong perspective from senior management With management concepts and tools enabling leaders in the pharmaceutical industry to cope with new challenges and trends Includes supplementary material: sn.pub/extras

Autorentext
Prof. Dr. Oliver Gassmann ist Professor für Technologiemanagement und Direktor des Instituts für Technologiemanagement an der Universität St. Gallen.

Inhalt
Innovation: Key to Success in the Pharmaceutical Industry.- The Industry Challenge: Do You Really Want to Be in This Business?.- The Science and Technology Challenge: How to Find New Drugs.- The Pipeline Management Challenge: How to Organize Innovation.- The Internationalization Challenge: Where to Get Access to Innovation.- Management Answers to Pharmaceutical R&D Challenges.- Future Directions and Trends.